5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-amine dihydrochloride, 95.0%, 500mg

3-(Toluene-4-sulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester, 500mg

N-(tert-Butyl)-2-chloro-6-methylisonicotinamide, 98%, 250mg

(trans,trans)-4-Ethyl-4'-(4-(trifluoromethoxy)phenyl)-1,1'-bi(cyclohexane), 97%, 10g

6-BROMO-3-CHLORO-2-METHYLQUINOXALINE, 95.0%, 100mg

(3S)-3-Methylpiperidin-3-ol hydrochloride, 98%, 250mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-(triphenylmethyl)-L-cysteine>98.0%(HPLC)(T)5g

1,4-Dibenzyl-1,4-diazepan-6-ol, 95+%, 5g

4-PYRIDIN-4-YL-THIAZOLE-2-CARBOXYLIC ACID ETHYL ESTER HYDROBROMIDE, 95.0%, 1g

NADP (disodium salt), 100mg

Filtration unit with nylon membrane Pore size 0.2 μm, 1000 ml, 1000 ml, 90 mm, 12 Piece(s)

3-cyclohexyl-1H-pyrazol-5-amine, 98%, 5g

2-(1h-Inden-3-yl)ethan-1-amine hydrochloride, 95%, 1g